Arvee Laboratories (India) Limited
Arvee Laboratories (India) Limited (ARVEE) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
arveelabs.com(opens the company website in a new tab)Key metrics
Price as of 2026-09-03
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Mar 2025 | Jun 2025 | Sept 2025 |
|---|---|---|---|
| Sales | 6 Cr | 7 Cr | 3 Cr |
| Operating expenses (approx.) | 6 Cr | 7 Cr | 3 Cr |
| EBITDA | 0.22 Cr | 0.34 Cr | 0.13 Cr |
| OPM % | 3.5% | 4.6% | 3.7% |
| Other income | 0.21 Cr | 0.17 Cr | 0.23 Cr |
| Interest | 0.07 Cr | 0.04 Cr | 0.04 Cr |
| Depreciation | 0.27 Cr | 0.29 Cr | 0.30 Cr |
| Profit before tax | 0.09 Cr | 0.17 Cr | 0.01 Cr |
| Tax % | 26.3% | 2.9% | 1.9% |
| Net profit | 0.07 Cr | 0.17 Cr | 0.01 Cr |
| EPS (₹) | ₹0.06 | ₹0.15 | ₹0.01 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2025 | TTM |
|---|---|---|
| Sales | 38 Cr | Sign in for TTM |
| Operating expenses (approx.) | 35 Cr | Sign in for TTM |
| EBITDA | 4 Cr | Sign in for TTM |
| OPM % | 9.4% | Sign in for TTM |
| Other income | 0.66 Cr | Sign in for TTM |
| Interest | 0.25 Cr | Sign in for TTM |
| Depreciation | 1 Cr | Sign in for TTM |
| Profit before tax | 3 Cr | Sign in for TTM |
| Tax % | 25.2% | Sign in for TTM |
| Net profit | 2 Cr | Sign in for TTM |
| EPS (₹) | ₹1.95 | Sign in for TTM |
| Dividend payout % | 0.0% | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2025 |
|---|---|
| Equity capital | 11 Cr |
| Reserves | 20 Cr |
| Borrowings | 1 Cr |
| Other liabilities | 6 Cr |
| Total liabilities | 38 Cr |
| Fixed assets (net) | 15 Cr |
| CWIP | 0.73 Cr |
| Investments | 0 Cr |
| Inventories | 5 Cr |
| Trade receivables | 8 Cr |
| Cash & bank | 0.21 Cr |
| Other assets | 9 Cr |
| Total assets | 38 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2025 |
|---|---|
| Cash from operating activity | -0.04 Cr |
| Cash from investing | -1 Cr |
| Cash from financing | -0.21 Cr |
| Net cash flow | -2 Cr |
| Free cash flow (OCF − Capex) | -2 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2025 |
|---|---|
| ROCE % | 9.7% |
| ROE % | 6.9% |
| Debtor days | 79 |
| Inventory days | 88 |
| Days payable | 63 |
| Cash conversion cycle | 104 |
| Debt / equity | 0.03 |
| Current ratio | 4.75 |
| Net debt / EBITDA | 0.23 |